Yuji Ishimatsu Selected Research

SELAPINA

11/2006

[A case of rheumatoid lung complicated by SELAPINA-induced pneumonia].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuji Ishimatsu Research Topics

Disease

18	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2022 - 01/2010
8	Idiopathic Pulmonary Fibrosis 11/2021 - 09/2010
6	Pneumonia (Pneumonitis) 12/2021 - 09/2005
5	Pulmonary Fibrosis (Fibrosing Alveolitis) 06/2022 - 03/2010
5	Dyspnea (Shortness of Breath) 11/2020 - 11/2012
4	Respiratory Insufficiency (Respiratory Failure) 03/2022 - 07/2010
4	Sarcoidosis (Schaumann Disease) 11/2020 - 01/2010
4	Fibrosis (Cirrhosis) 01/2020 - 01/2011
3	Inflammation (Inflammations) 06/2022 - 01/2009
3	Myositis (Idiopathic Inflammatory Myopathies) 03/2022 - 12/2011
3	Dermatomyositis (Dermatopolymyositis) 03/2022 - 01/2015
3	Lung Diseases (Lung Disease) 11/2020 - 09/2010
3	Muscle Weakness 11/2020 - 12/2011
3	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2016 - 09/2004
3	Infections 01/2016 - 01/2010
3	Vascular Diseases (Vascular Disease) 05/2015 - 06/2010
3	Cryptogenic Organizing Pneumonia 05/2015 - 01/2009
2	Cough 12/2022 - 11/2012
2	Diffuse panbronchiolitis 12/2022 - 09/2010
2	Human Influenza (Influenza) 01/2021 - 01/2016
2	Neoplasms (Cancer) 09/2020 - 01/2014
2	Bronchiectasis 03/2019 - 01/2017
2	Rheumatoid Arthritis 01/2019 - 12/2012
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 09/2018 - 01/2014
2	Pneumothorax 01/2017 - 09/2014
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 02/2016 - 09/2010
2	Pulmonary Emphysema 01/2016 - 12/2012
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 04/2013 - 01/2011
2	Lymphadenopathy 12/2011 - 09/2006
2	Hemorrhage 01/2010 - 01/2010
2	Granuloma 01/2010 - 01/2002
1	Sinusitis 12/2022
1	Hermanski-Pudlak Syndrome (Hermansky-Pudlak Syndrome) 06/2022
1	Diarrhea 06/2022
1	Pulmonary Alveolar Proteinosis 03/2022
1	Polymyositis 03/2022
1	Root Caries 12/2021
1	Foreign Bodies (Foreign Body) 12/2021
1	COVID-19 01/2021
1	Pneumoconiosis 11/2020
1	Berylliosis 11/2020
1	Lung Neoplasms (Lung Cancer) 09/2020
1	Albinism 11/2019
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2019

Drug/Important Bio-Agent (IBA)

7	SteroidsIBA 06/2022 - 01/2007
7	CollagenIBA 01/2021 - 06/2010
7	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2009
6	MacrolidesIBA 12/2022 - 09/2004
5	Pharmaceutical PreparationsIBA 06/2022 - 01/2010
5	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 01/2011
4	Immunosuppressive Agents (Immunosuppressants)IBA 06/2022 - 01/2014
4	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 03/2022 - 02/2015
4	AntibodiesIBA 03/2022 - 01/2010
4	HSP47 Heat-Shock Proteins (Heat Shock Protein 47)IBA 01/2021 - 09/2013
3	DefensinsIBA 03/2018 - 02/2015
3	ImmunosorbentsIBA 03/2018 - 04/2012
3	EnzymesIBA 03/2018 - 04/2012
3	Clarithromycin (Biaxin)FDA LinkGeneric 01/2016 - 01/2010
3	Bleomycin (Blenoxane)FDA LinkGeneric 06/2012 - 03/2010
3	Prednisolone (Predate)FDA LinkGeneric 12/2011 - 11/2006
2	HLA Antigens (Human Leukocyte Antigens)IBA 12/2022 - 11/2021
2	Erythromycin (Erycette)FDA LinkGeneric 12/2022 - 01/2014
2	HLA-B54 antigenIBA 12/2022 - 11/2021
2	AntigensIBA 12/2022 - 09/2005
2	Oxygen (Dioxygen)IBA 06/2022 - 01/2011
2	Molecular Chaperones (Chaperone, Molecular)IBA 01/2021 - 06/2010
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 09/2020 - 06/2010
2	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 12/2011
2	Peptides (Polypeptides)IBA 03/2018 - 02/2015
2	InterferonsIBA 01/2016 - 01/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2016 - 04/2010
2	Interleukin-8 (Interleukin 8)IBA 12/2015 - 05/2015
2	pirfenidoneIBA 01/2014 - 06/2012
2	TenascinIBA 10/2012 - 01/2009
2	Collagen Type I (Type I Collagen)IBA 06/2012 - 01/2011
2	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 06/2012 - 01/2010
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2010 - 01/2010
2	Fas Ligand Protein (Fas Ligand)IBA 09/2004 - 01/2002
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 06/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2022
1	Peroxidase (Myeloperoxidase)IBA 06/2022
1	AutoantibodiesIBA 03/2022
1	SilverIBA 12/2021
1	Biological ProductsIBA 01/2021
1	AluminumIBA 11/2020
1	BerylliumIBA 11/2020
1	MetalsIBA 11/2020
1	Melanins (Melanin)IBA 11/2019
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2019
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2018
1	Pulmonary Surfactant-Associated Protein A (Surfactant Protein A)IBA 03/2018
1	Indicators and Reagents (Reagents)IBA 03/2018
1	SmokeIBA 01/2018

Therapy/Procedure

15	Therapeutics 12/2022 - 11/2006
2	Activities of Daily Living (ADL) 12/2021 - 01/2016
2	Traction 03/2019 - 01/2017
2	X-Ray Film 04/2010 - 09/2006
1	Aftercare (After-Treatment) 03/2022
1	Surgical Instruments (Clip) 12/2021
1	Bronchoscopes 12/2021